Canadian Medical Center Co. reported a net profit of SAR 3.4 million for H1 2024, down 58% from SAR 8 million a year earlier due to its transformation project.
| Item | 6m 2023 | 6m 2024 | Change |
|---|---|---|---|
| Revenues | 45.22 | 51.22 | 13.3 % |
| Net Income | 8.00 | 3.37 | (57.9 %) |
| Average Shares | 77.00 | 77.00 | - |
| EPS (Riyals) | 0.10 | 0.04 | (57.9 %) |
Revenue increased by 13.3% year-on-year to SAR 51.22 million, driven by the company’s expansion and growth strategy, including opening new branches in promising and more profitable areas and sectors.
Total shareholders’ equity, no minority interest, fell to SAR 88.05 million by June 30, 2024, compared to SAR 90.75 million a year ago.
|
Historical Development of Semi-Annual Data |
|||
|
Period |
Revenue (SAR mln) |
Net Profit (SAR mln) |
Earnings Per Share (SAR) |
|
H1 2020 |
29.83 |
8.4 |
0.11 |
|
H2 2020 |
34.38 |
7.75 |
0.10 |
|
H1 2021 |
30.18 |
4.96 |
0.06 |
|
H2 2021 |
40.46 |
9.1 |
0.12 |
|
H1 2022 |
38.92 |
7.94 |
0.10 |
|
H2 2022 |
42.31 |
7.71 |
0.10 |
|
H1 2023 |
45.22 |
8.00 |
0.10 |
|
H2 2023 |
55.12 |
7.71 |
0.10 |
|
H1 2024 |
51.22 |
3.36 |
0.04 |
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}